2/ #GhostManagement#TechnologicalCapture #ManagedCompetition
"Companies’ connections are like a plate of spaghetti. They have licensing agreements with each other; they even promote each other’s drugs in a number of instances."
3/ #GhostManagement#COI#ProfessionalCapture
"Conversely, doctors who take money from one drug company anticipate getting money from other drug companies—and typically that’s the case. We’ve got doctors who’ve taken money from about 15 different companies in a single year."
4/ #GhostManagement#ScientificCapture#MediaCapture
"Articles will come out that are so effusive about a drug, and then later you find out there were conflicts either with the people quoted or with the study. It’s continuous, both in the media reports and medical journals."
5/ #GhostManagement#RegulatoryCapture
“Pharmaceutical companies are viewed as “scientific” and FDA advisors who expose the dangers or lack of efficacy in a drug are painted as “emotional.” It’s an upside-down world."
6/ #GhostManagement#RegulatoryCapture
"The FDA will say that they can’t find anybody who’s independent to be on their review panels because all the experts get money from industry.”
8/ #MediaCapture
"Whenever anybody dares to criticize or speak out, industry has an army—PR marketing people, lawyers, patient groups they fund, academics and professional societies they fund—all come out of the woodwork to attack and drown out any counter opinion."
2/ Le constat de récupération des instruments #EBM par #BigPharma et de leur détournement à des fins commerciales est partagé par de nombreux observateurs p.ex. Jack E James en 2017 tinyurl.com/yygrvgwa
3/ Les critiques portent notamment sur les #RCT #BigPharma ayant (encore) besoin de #RCT avec des résultats favorables pour obtenir l'#AMM de nouveaux produits ou des extensions d’indication